ARA-290
- Low stock - 10 items left
- Backordered, shipping soon
ARA-290 (Hematopoietic Peptide Analogue)
Targeted Tissue Modulation Research Compound
Product Overview
ARA-290 is a synthetic peptide analogue derived from the innate repair receptor (IRR)–activating region of erythropoietin. This research compound is specifically engineered to interact with the IRR pathway without triggering erythropoiesis. Scientists utilize ARA-290 to investigate mechanisms of cellular protection, immune modulation, and metabolic regulation.
Key Research Applications
-
Inflammatory Signaling: Widely investigated for its potential to modulate systemic and localized inflammatory responses.
-
Neural Protection: Supports studies focused on neural response and the mitigation of tissue damage in neurological models.
-
IRR Pathway Exploration: Valued for its focused interaction with the innate repair receptor to study tissue-protective biological pathways.
-
Metabolic Research: Evaluated for its influence on metabolic regulation and related physiological processes.
-
Tissue Repair: Frequently used in research models exploring cellular protection and endogenous repair mechanisms.
Why Researchers Choose ARA-290
-
High-Purity Standard: Synthesized for controlled laboratory environments and consistent performance.
-
Proven Stability: Demonstrates high stability under recommended scientific storage conditions.
-
Ease of Use: Specifically designed for efficient reconstitution in both in-vitro and in-vivo research models.
-
Application Versatility: Suitable for a broad range of scientific applications involving cellular protection.
Research Notice: This compound is strictly for laboratory and scientific research use only. Not for human or animal consumption, medical treatment, or therapeutic use.